Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
988,943
-
Share change
-
-345,628
-
Total reported value
-
$168,120,054
-
Price per share
-
$170.00
-
Number of holders
-
59
-
Value change
-
-$58,562,873
-
Number of buys
-
28
-
Number of sells
-
23
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2025
As of 31 Dec 2025,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
988,943 shares.
The largest 10 holders included
WEDGE CAPITAL MANAGEMENT L L P/NC, Retirement Systems of Alabama, Perpetual Ltd, SG Americas Securities, LLC, Aberdeen Group plc, BTC Capital Management, Inc., Hennion & Walsh Asset Management, Inc., CWA Asset Management Group, LLC, Louisiana State Employees Retirement System, and Philip James Wealth Mangement, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.